Blog

Intravenous UC-MSCs for Ischemic Stroke: What the MERIT Phase 1 Trial Tells Us

The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.

Jun 19, 2026

Stem Cell Therapy ‘Jump-Starts’ Brain Repair After Stroke: A New Era in Neurological Recovery

Imagine a world where the devastating effects of a stroke could be reversed, even weeks after the event. This isn’t science fiction—it’s the promising reality emerging from groundbreaking research in stem cell therapy. A…

Feb 17, 2025

Page 1 of 1 — 2 posts